Evaluation of models predicting insignificant prostate cancer to select men for active surveillance of prostate cancer

被引：0
|
作者：
L-M Wong
D E Neal
A Finelli
S Davis
C Bonner
J Kapoor
J Trachtenberg
B Thomas
C M Hovens
A J Costello
N M Corcoran
机构：
[1] St Vincent's Hospital,Department of Urology and Surgery
[2] Fitzroy,Department of Urology and Surgery
[3] Victoria,Division of Uro
[4] Australia,oncology, Department of Surgical Oncology
[5] Austin Health,The Australian Prostate Cancer Centre at Epworth and Departments of Urology and Surgery
[6] University of Melbourne,undefined
[7] Heidelberg,undefined
[8] Victoria,undefined
[9] Australia,undefined
[10] Cancer Research UK Cambridge Institute,undefined
[11] University of Cambridge,undefined
[12] Li Ka Shing Centre,undefined
[13] Cambridge,undefined
[14] UK,undefined
[15] Princess Margaret Hospital,undefined
[16] University of Toronto,undefined
[17] Toronto,undefined
[18] Ontario,undefined
[19] Canada.,undefined
[20] Royal Melbourne Hospital and University of Melbourne,undefined
[21] Parkville,undefined
[22] Victoria,undefined
[23] Australia,undefined
来源：
Prostate Cancer and Prostatic Diseases | 2015年 / 18卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：137 / 143
页数：6
相关论文
共 50 条
  • [1] Evaluation of models predicting insignificant prostate cancer to select men for active surveillance of prostate cancer
    Wong, L-M
    Neal, D. E.
    Finelli, A.
    Davis, S.
    Bonner, C.
    Kapoor, J.
    Trachtenberg, J.
    Thomas, B.
    Hovens, C. M.
    Costello, A. J.
    Corcoran, N. M.
    [J]. PROSTATE CANCER AND PROSTATIC DISEASES, 2015, 18 (02) : 137 - 143
  • [2] VALIDATION OF ACTIVE SURVEILLANCE CRITERIA FOR PATHOLOGICAL INSIGNIFICANT PROSTATE CANCER IN JAPANESE MEN
    Yamada, Yasutaka
    Sakamoto, Shinichi
    Saduka, Tomokazu
    Gotoh, Yusuke
    Kaga, Mayuko
    Yanagisawa, Mitsuru
    Kawamura, Kouji
    Kamiya, Naoto
    Imamoto, Takashi
    Nihei, Naoki
    Suzuki, Hiroyoshi
    Ichikawa, Tomohiko
    [J]. JOURNAL OF UROLOGY, 2014, 191 (04): : E715 - E716
  • [3] Validation of active surveillance criteria for pathologically insignificant prostate cancer in Asian men
    Yamada, Yasutaka
    Sakamoto, Shinichi
    Sazuka, Tomokazu
    Goto, Yusuke
    Kawamura, Koji
    Imamoto, Takashi
    Nihei, Naoki
    Suzuki, Hiroyoshi
    Akakura, Koichiro
    Ichikawa, Tomohiko
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2016, 23 (01) : 49 - 54
  • [4] USING THE STEYERBERG NOMOGRAM FOR INSIGNIFICANT PROSTATE CANCER TO SELECT MEN WITH SCREEN-DETECTED EARLY PC FOR ACTIVE SURVEILLANCE
    Van Den Bergh, R. C. N.
    Roobol, M. J.
    Wolters, T.
    Van Leeuwen, P. J.
    Steyerberg, E. W.
    Shroder, F. H.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (04) : 123 - 123
  • [5] Multiparametric magnetic resonance imaging and active surveillance: How to better select insignificant prostate cancer?
    Porpiglia, Francesco
    Cantiello, Francesco
    De Luca, Stefano
    De Pascale, Agostino
    Manfredi, Matteo
    Mele, Fabrizio
    Bollito, Enrico
    Cirillo, Stefano
    Damiano, Rocco
    Russo, Filippo
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2016, 23 (09) : 752 - 757
  • [6] Editorial Comment to Validation of active surveillance criteria for pathologically insignificant prostate cancer in Asian men
    Abreu, Andre Luis de Castro
    Ukimura, Osamu
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2016, 23 (01) : 55 - 55
  • [7] Active Surveillance in Younger Men With Prostate Cancer
    Leapman, Michael S.
    Cowan, Janet E.
    Nguyen, Hao G.
    Shinohara, Katsuto K.
    Perez, Nannette
    Cooperberg, Matthew R.
    Catalona, William J.
    Carroll, Peter R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (17) : 1898 - +
  • [8] METASTATIC PROSTATE CANCER IN MEN ON ACTIVE SURVEILLANCE
    Yamamoto, Toshihiro
    Vespirini, Danny
    Loblaw, Andrew
    Mamedov, Alezandre
    Zhang, Liying
    Klotz, Laurence
    [J]. JOURNAL OF UROLOGY, 2015, 193 (04): : E29 - E29
  • [9] Active surveillance should be considered for select men with Grade Group 2 prostate cancer
    Pekala, Kelly R.
    Bergengren, Oskar
    Eastham, James A.
    Carlsson, Sigrid V.
    [J]. BMC UROLOGY, 2023, 23 (01)
  • [10] Active surveillance should be considered for select men with Grade Group 2 prostate cancer
    Kelly R. Pekala
    Oskar Bergengren
    James A. Eastham
    Sigrid V. Carlsson
    [J]. BMC Urology, 23
12345